<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/67E7B82E-2EE4-4507-8429-7BDD48B82E70/chart/price-vs-fair-value?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/67E7B82E-2EE4-4507-8429-7BDD48B82E70/chart/price-vs-fair-value"/></p>
<p>TSE:6472 1 年股價與公允價值對比</p>
<p>探索來自社區的 NTN 公允價值並選擇您的觀點</p>
<p><strong>NTN Corporation</strong>（TSE:6472）的股東本週將感到高興，因為股價上漲了 20%，達到 308 日元，此次上漲是由於其最新的第一季度業績。報告的收入為 1990 億日元，略微低於預期，低於預測 2.3%，但盈利超出預期——法定利潤為每股 2.25 日元，較分析師預期的虧損有了顯著改善。分析師通常會在每次財報發佈時更新他們的預測，我們可以根據他們的估計判斷他們對公司的看法是否發生了變化，或者是否有新的關注點。我們認為讀者會發現分析師最新的（法定）財報後預測對明年的情況很有趣。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行探索。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874029-earnings-and-revenue-growth-1-dark-2/1754519870255?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874029-earnings-and-revenue-growth-1-dark-2/1754519870255"/></p>
<p>TSE:64722025 年 8 月 6 日的盈利和收入增長</p>
<p>在最新的業績發佈後，NTN 的五位分析師的共識是 2026 年的收入為 7895 億日元，這將反映出與去年業績相比，收入明顯下降 3.0%。預計虧損將大幅減少，縮減 80% 至 8.73 日元。在此之前，市場共識預計收入為 8073 億日元，每股虧損 1.96 日元。儘管今年的收入預期下降，但每股虧損預期也有非常顯著的增加，這表明市場共識對該股的看法有些混合。</p>
<p>查看我們對 NTN 的最新分析</p>
<p>平均目標價基本保持不變，為 246 日元，這可能隱含地表明，較弱的盈利前景預計不會對估值產生長期影響。然而，過於關注單一目標價可能是不明智的，因為市場共識目標實際上是分析師目標價的平均值。因此，一些投資者喜歡查看估計範圍，以瞭解對公司估值是否存在分歧意見。目前，最看漲的分析師將 NTN 的估值定為每股 300 日元，而最看跌的則定為 220 日元。正如您所見，分析師對該股的未來並不完全一致，但估計範圍仍然相對狹窄，這可能表明結果並非完全不可預測。</p>
<p>現在從更大的角度來看，我們可以通過將這些預測與過去的表現和行業增長預期進行比較來理解這些預測。這些估計暗示收入預計將放緩，預計到 2026 年底年均下降 4.0%。這表明與過去五年的年均增長 9.4% 相比，收入將顯著減少。相比之下，我們的數據表明，同一行業中其他公司（有分析師覆蓋）的收入預計在可預見的未來將年均增長 4.6%。因此，儘管其收入預計將縮減，但這一陰雲並沒有帶來任何好消息——NTN 預計將落後於更廣泛的行業。</p>
<h2>結論</h2>
<p>最重要的是要注意明年虧損增加的預測，這表明 NTN 的情況可能並不樂觀。不幸的是，他們還下調了收入預期，我們的數據表明與更廣泛的行業相比表現不佳。儘管如此，每股收益對企業的內在價值更為重要。共識目標價沒有實質性變化，這表明企業的內在價值在最新估計中沒有發生重大變化。</p>
<p>基於這一思路，我們認為企業的長期前景比明年的盈利更為相關。在 Simply Wall St，我們有 NTN 到 2028 年的完整分析師估計，您可以在我們的平台上免費查看。</p>
<p>我們不想過於潑冷水，但我們確實發現了 <strong>NTN 的 3 個警示信號</strong>（其中 1 個有點不愉快！），您需要注意。</p>

6472

<p>NTN Corporation（東京證券交易所代碼：6472）的股價上漲 20%，達到 308 日元，此前其盈利超出預期，報告每股法定利潤為 2.25 日元，儘管收入略微未達預期，為 1990 億日元。分析師預測 2026 年收入將下降至 7895 億日元，損失將減少 80%，降至 8.73 日元。平均目標價維持在 246 日元，估計範圍在 220 日元至 300 日元之間。儘管 NTN 的收入預計將落後於行業增長，但共識目標價表明內在價值沒有重大變化。然而，損失預測的增加引發了對公司未來表現的擔憂</p>

<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/67E7B82E-2EE4-4507-8429-7BDD48B82E70/chart/price-vs-fair-value" alt="" original-src="https://images.simplywall.st/company/67E7B82E-2EE4-4507-8429-7BDD48B82E70/chart/price-vs-fair-value"/></p>
<p>TSE:6472 1 Year Share Price vs Fair Value</p>
<div class="lb-trans"><p>TSE:6472 1 年股價與公允價值對比</p>
</div><p>Explore NTN's Fair Values from the Community and select yours</p>
<div class="lb-trans"><p>探索來自社區的 NTN 公允價值並選擇您的觀點</p>
</div><p>Shareholders of <strong>NTN Corporation</strong> (TSE:6472) will be pleased this week, given that the stock price is up 20% to JP¥308 following its latest first-quarter results. Revenues of JP¥199b reported a marginal miss, falling short of forecasts by 2.3%, but earnings were better than expected - statutory profits came in at JP¥2.25 per share, a nice change from the loss the analysts expected. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.</p>
<div class="lb-trans"><p><strong>NTN Corporation</strong>（TSE:6472）的股東本週將感到高興，因為股價上漲了 20%，達到 308 日元，此次上漲是由於其最新的第一季度業績。報告的收入為 1990 億日元，略微低於預期，低於預測 2.3%，但盈利超出預期——法定利潤為每股 2.25 日元，較分析師預期的虧損有了顯著改善。分析師通常會在每次財報發佈時更新他們的預測，我們可以根據他們的估計判斷他們對公司的看法是否發生了變化，或者是否有新的關注點。我們認為讀者會發現分析師最新的（法定）財報後預測對明年的情況很有趣。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行探索。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/874029-earnings-and-revenue-growth-1-dark-2/1754519870255" alt="" original-src="https://images.simplywall.st/asset/chart/874029-earnings-and-revenue-growth-1-dark-2/1754519870255"/></p>
<p>TSE:6472 Earnings and Revenue Growth August 6th 2025</p>
<div class="lb-trans"><p>TSE:64722025 年 8 月 6 日的盈利和收入增長</p>
</div><p>After the latest results, the consensus from NTN's five analysts is for revenues of JP¥789.5b in 2026, which would reflect a discernible 3.0% decline in revenue compared to the last year of performance. Losses are predicted to fall substantially, shrinking 80% to JP¥8.73. Before this latest report, the consensus had been expecting revenues of JP¥807.3b and JP¥1.96 per share in losses. While this year's revenue estimates dropped there was also a very substantial increase in loss per share expectations, suggesting the consensus has a bit of a mixed view on the stock.</p>
<div class="lb-trans"><p>在最新的業績發佈後，NTN 的五位分析師的共識是 2026 年的收入為 7895 億日元，這將反映出與去年業績相比，收入明顯下降 3.0%。預計虧損將大幅減少，縮減 80% 至 8.73 日元。在此之前，市場共識預計收入為 8073 億日元，每股虧損 1.96 日元。儘管今年的收入預期下降，但每股虧損預期也有非常顯著的增加，這表明市場共識對該股的看法有些混合。</p>
</div><p>View our latest analysis for NTN</p>
<div class="lb-trans"><p>查看我們對 NTN 的最新分析</p>
</div><p>The average price target was broadly unchanged at JP¥246, perhaps implicitly signalling that the weaker earnings outlook is not expected to have a long-term impact on the valuation. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. Currently, the most bullish analyst values NTN at JP¥300 per share, while the most bearish prices it at JP¥220. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.</p>
<div class="lb-trans"><p>平均目標價基本保持不變，為 246 日元，這可能隱含地表明，較弱的盈利前景預計不會對估值產生長期影響。然而，過於關注單一目標價可能是不明智的，因為市場共識目標實際上是分析師目標價的平均值。因此，一些投資者喜歡查看估計範圍，以瞭解對公司估值是否存在分歧意見。目前，最看漲的分析師將 NTN 的估值定為每股 300 日元，而最看跌的則定為 220 日元。正如您所見，分析師對該股的未來並不完全一致，但估計範圍仍然相對狹窄，這可能表明結果並非完全不可預測。</p>
</div><p>Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 4.0% by the end of 2026. This indicates a significant reduction from annual growth of 9.4% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 4.6% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - NTN is expected to lag the wider industry.</p>
<div class="lb-trans"><p>現在從更大的角度來看，我們可以通過將這些預測與過去的表現和行業增長預期進行比較來理解這些預測。這些估計暗示收入預計將放緩，預計到 2026 年底年均下降 4.0%。這表明與過去五年的年均增長 9.4% 相比，收入將顯著減少。相比之下，我們的數據表明，同一行業中其他公司（有分析師覆蓋）的收入預計在可預見的未來將年均增長 4.6%。因此，儘管其收入預計將縮減，但這一陰雲並沒有帶來任何好消息——NTN 預計將落後於更廣泛的行業。</p>
</div><h2>The Bottom Line</h2>
<div class="lb-trans"><h2>結論</h2>
</div><p>The most important thing to note is the forecast of increased losses next year, suggesting all may not be well at NTN. Unfortunately, they also downgraded their revenue estimates, and our data indicates underperformance compared to the wider industry. Even so, earnings per share are more important to the intrinsic value of the business. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.</p>
<div class="lb-trans"><p>最重要的是要注意明年虧損增加的預測，這表明 NTN 的情況可能並不樂觀。不幸的是，他們還下調了收入預期，我們的數據表明與更廣泛的行業相比表現不佳。儘管如此，每股收益對企業的內在價值更為重要。共識目標價沒有實質性變化，這表明企業的內在價值在最新估計中沒有發生重大變化。</p>
</div><p>Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for NTN going out to 2028, and you can see them free on our platform here..</p>
<div class="lb-trans"><p>基於這一思路，我們認為企業的長期前景比明年的盈利更為相關。在 Simply Wall St，我們有 NTN 到 2028 年的完整分析師估計，您可以在我們的平台上免費查看。</p>
</div><p>We don't want to rain on the parade too much, but we did also find <strong>3 warning signs for NTN</strong> (1 is a bit unpleasant!) that you need to be mindful of.</p>
<div class="lb-trans"><p>我們不想過於潑冷水，但我們確實發現了 <strong>NTN 的 3 個警示信號</strong>（其中 1 個有點不愉快！），您需要注意。</p>
</div>

NTN 公司剛剛超出盈利預期：分析師認為接下來會發生什麼